Home
Closed

Contract for the Provision for the Manufacture of Vaccine Antigen

Deadline:16 Oct 2025, 00:00 GMT+1

Tender information

TED EU

Dublin, Ireland

Type
16
Procedure
open
Ref. number
634422-2025
Estimated value
100,000 EUR
CPV
33651600

UCD has developed a series of bacterial antigens which have proven effective in proof-of-concept studies and which the aim is to further develop and translate to humans. The lead target antigen is 22 kDa cytosolic bacter

Show all tender information

Documents

Show all important dates